PHK
BHVN

Point72 Hong Kong’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Point72 Hong Kong’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-967
Closed -$146K – 1896
2022
Q3 		$146K Sell
967
-655
-40% -$97.1K 0.01% 1132
2022
Q2 		$236K Sell
1,622
-68
-4% -$8.69K 0.01% 936
2022
Q1 		$200K Buy
+1,690
New +$211K 0.01% 972
2021
Q3 		– Sell
-1,209
Closed -$117K – 2639
2021
Q2 		$117K Buy
+1,209
New +$98.1K ﹤0.01% 1286
2020
Q3 		– Sell
-1,002
Closed -$73K – 1708
2020
Q2 		$73K Buy
+1,002
New +$53.3K 0.01% 684
2019
Q3 		– Sell
-4,883
Closed -$214K – 1560
2019
Q2 		$214K Buy
4,883
+1,911
+64% +$108K 0.06% 306
2019
Q1 		$153K Buy
2,972
+1,511
+103% +$65.3K 0.06% 252
2018
Q4 		$54K Buy
1,461
+1,076
+279% +$38.8K 0.03% 299
2018
Q3 		$14K Buy
+385
New +$14.2K ﹤0.01% 635
2018
Q1 		– Sell
-1,187
Closed -$32K – 1331
2017
Q4 		$32K Buy
+1,187
New +$32.7K 0.02% 291
2017
Q3 		– Sell
-187
Closed -$5K – 1237
2017
Q2 		$5K Buy
+187
New +$4.31K 0.01% 563

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Point72 Hong Kong's BHVN Position: Q4 2022 in Review

Point72 Hong Kong sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 967 shares — an estimated $146K sold.

Point72 Hong Kong first reported a position in BHVN in Q2 2017 and held it in 11 quarters. The position peaked at $236K in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Point72 Hong Kong reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 967 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $146K.
  • Point72 Hong Kong first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 11 quarters.
  • Point72 Hong Kong's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $236K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.